Related Experiment Video
Updated: May 14, 2025
Analyzing Melts and Fluids from Ab Initio Molecular Dynamics Simulations with the UMD Package
Published on: September 17, 2021
Molecular Dynamics Studies on Trypanosoma cruzi Dihydroorotate Dehydrogenase Complexes: An Analysis of the Inhibitor
Eldio G Santos1, Luiz A P Flores-Junior1, Camilo H S Lima2
1Laboratório de Química Medicinal, Departamento de Tecnologia Farmacêutica, Faculdade de Farmácia, Universidade Federal Fluminense, Niterói, RJ 24241-000, Brazil.
Insights
Developing new drugs for Chagas disease is crucial. This study reveals how ligand size and active site flexibility impact Trypanosoma cruzi dihydroorotate dehydrogenase (TcDHODH) inhibition, guiding the creation of more effective treatments.
Area of Science:
- Biochemistry
- Drug Discovery
- Parasitology
Background:
- Chagas disease is a major global health concern with limited treatment options, especially in advanced stages.
- Trypanosoma cruzi dihydroorotate dehydrogenase (TcDHODH) presents a promising therapeutic target for novel anti-parasitic drugs.
- Current treatments for Chagas disease exhibit low efficacy and adverse effects, necessitating the development of new therapeutic strategies.
Purpose of the Study:
- To investigate the structural and dynamic factors governing the inhibition of Trypanosoma cruzi dihydroorotate dehydrogenase (TcDHODH).
- To elucidate the role of ligand properties and enzyme active site dynamics in TcDHODH inhibition.
- To provide insights for the rational design of potent and selective TcDHODH inhibitors.
Main Methods:
- Conducted 100 ns molecular dynamics simulations for 11 distinct ligand-TcDHODH complexes.
- Analyzed ligand size, conformation, and their influence on enzyme active site dynamics.
- Examined hydrogen bonding, electrostatic, and hydrophobic interactions within the enzyme-ligand complexes.
Main Results:
- Ligand size and conformation significantly influence TcDHODH inhibition.
- Enzyme active site flexibility is critical for its function and inhibition.
- Small ligands favor closed enzyme conformations, while larger ligands induce open conformations.
- Key hydrogen bonds and interactions within the S1, S2, and S3 subsites stabilize ligand-enzyme complexes.
Conclusions:
- Understanding ligand-enzyme interactions and conformational changes is vital for developing effective TcDHODH inhibitors.
- Ligand size and flexibility are key determinants of TcDHODH inhibition efficacy.
- This research facilitates the design of improved drug candidates for Chagas disease treatment.
Abstract:
Chagas disease remains a significant global health problem. Current etiological treatment is limited due to its low efficacy in the advanced stage of the disease and adverse effects. Trypanosoma cruzi dihydroorotate dehydrogenase (TcDHODH) is a promising target for developing new drugs. This study explored the structural and dynamic factors influencing its inhibition. The results from the 100 ns molecular dynamics simulations of 11 ligand-TcDHODH complexes revealed that ligand size and conformation play crucial roles in enzyme inhibition, with flexibility in the active site being essential for enzyme function. Small ligands tend to maintain a closed conformation, while larger ligands induce open conformations. The results further demonstrate ligand-induced conformational changes and the role of key hydrogen bonds in stabilizing the ligand-enzyme complex. Electrostatic and hydrophobic interactions between ligands and the enzyme's S1, S2, and S3 subsites contribute to inhibition. Understanding these factors facilitates the development of potent and selective TcDHODH inhibitors for the treatment of Chagas disease.
